- Home
- DERM vs CBUS Comparison
DERM vs CBUS Comparison
Compare DERM & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- CBUS
- Stock Information
- Founded
- DERM 2014
- CBUS 2010
- Country
- DERM United States
- CBUS United States
- Employees
- DERM N/A
- CBUS N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- CBUS Agricultural Chemicals
- Sector
- DERM Health Care
- CBUS Industrials
- Exchange
- DERM Nasdaq
- CBUS Nasdaq
- Market Cap
- DERM 107.0M
- CBUS 127.1M
- IPO Year
- DERM 2021
- CBUS 2017
- Fundamental
- Price
- DERM $5.20
- CBUS $4.37
- Analyst Decision
- DERM Strong Buy
- CBUS Strong Buy
- Analyst Count
- DERM 3
- CBUS 3
- Target Price
- DERM $9.50
- CBUS $22.83
- AVG Volume (30 Days)
- DERM 145.7K
- CBUS 148.1K
- Earning Date
- DERM 11-12-2024
- CBUS 11-07-2024
- Dividend Yield
- DERM N/A
- CBUS N/A
- EPS Growth
- DERM N/A
- CBUS N/A
- EPS
- DERM N/A
- CBUS N/A
- Revenue
- DERM $57,771,000.00
- CBUS $4,152,999.00
- Revenue This Year
- DERM N/A
- CBUS $36.93
- Revenue Next Year
- DERM $37.38
- CBUS $236.45
- P/E Ratio
- DERM N/A
- CBUS N/A
- Revenue Growth
- DERM N/A
- CBUS 449.34
- 52 Week Low
- DERM $2.85
- CBUS $2.86
- 52 Week High
- DERM $8.11
- CBUS $23.18
- Technical
- Relative Strength Index (RSI)
- DERM 43.96
- CBUS 49.97
- Support Level
- DERM $5.00
- CBUS $4.30
- Resistance Level
- DERM $5.60
- CBUS $4.40
- Average True Range (ATR)
- DERM 0.45
- CBUS 0.55
- MACD
- DERM -0.04
- CBUS -0.07
- Stochastic Oscillator
- DERM 14.98
- CBUS 19.91
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.